Abstract:Stress response and depression have a crucial impact on modern society. Although the symptoms are well characterized, the molecular mechanisms underlying depression are largely unknown. Currently, the monoaminergic systems, especially serotonergic systems, have received the most attention in the research of depression. Accumulating evidence suggests that the glutamatergic and GABAergic system play an important role in the neurobiology and treatment of this disease. Multiple studies have shown that serotonin (5-HT) could modulate the neurotransmission of glutamic acid (Glu) and gamma-aminobutyric acid (GABA). The orbitofrontal cortex (OFC), which is involved in the pathophysiology and treatment of depression, plays a critical role in the control of higher brain functions and it mainly receives a dense 5-HT innervation from the dorsal raphe nucleus. There exist some 5-HT1A receptors on glutamatergic neurons and GABAergic neurons in the OFC. The purpose of this research was to elucidate the modulatory action of 5-HT1A receptor on the functions of Glu and GABA, which are the principal neurotransmitters mediating excitatory and inhibitory signals in the OFC respectively, in a well-established animal model of depression induced by chronic unpredictable mild stress (CUMS). We used CUMS in rat to mimic the core symptoms in human. Using the pharmacology approaches by microinjecting of 5-HT1A receptor agonist 8-OH-DPAT and its antagonist WAY100635 to the OFC, we detected behavioral changes by using behavior tests including sucrose preference test, open field test and tail suspension test. In addition, high-performance liquid chromatography (HPLC) was used to detect the level of neurotransmitters such as 5-HT, Glu and GABA in the OFC, respectively. CUMS group showed a variety of behavioral characteristics of depression, including a significant reduction in the sucrose preference, and locomotion, rearing and grooming in the open field test, and a significant increase in immobility time in the tail suspension test compared with control group. In addition, CUMS group showed that a significant increase in the concentration of Glu, but no significant difference in the levels of 5-HT and GABA in the OFC. Depression-like behaviors of CUMS rats were obviously ameliorated after being treated with 8-OH-DPAT, while the concentration of Glu was decreased. Rats received WAY100635 in control group showed similar depression-like behaviors and similar increased Glu levels. However, 5-HT level and GABA concentration were not altered in both groups received 8-OH-DPAT or WAY100635. These findings indicated that the mechanism through which CUMS could induce depression-like behaviors, probably is not due to the decrease of 5-HT level within the OFC, but because of excessive release of Glu that resulted from that 5-HT could not regulate glutamatergic neurons or the decrease of 5-HT1A receptor function on glutamatergic neurons within the OFC during stress. Our data suggested that 5-HT1A receptor in the OFC plays an important role in modulating the synthesis and release of Glu during CUMS. This study provided insights on modulation of glutamate transmission in depression.

THE ASSOCIATION OF HIPPOCAMPAL GLUTAMATE WITH DEPRESSION AND THE EFFECTS ON GASTRIC MOBILITY

Protective Effect of Gan Mai Da Zao Decoction in Unpredictable Chronic Mild Stress-Induced Behavioral and Biochemical Alterations.

[Modulation of Hippocampal Glutamate and NMDA/AMPA Receptor by Homocysteine in Chronic Unpredictable Mild Stress-Induced Rat Depression].

Relationships Between Hippocampal NMDA Receptor and NOS Positive Neurons in Myenteric Nerve Plexus in Stomach of CUMS Rats

Cortical Functional Hyperconnectivity in a Mouse Model of Depression and Selective Network Effects of Ketamine

Glutamate Chemical Exchange Saturation Transfer Imaging and Functional Alterations of Hippocampus in Rat Depression Model: A Pilot Study

Microglial glutaminase 1 mediates chronic restraint stress-induced depression-like behaviors and synaptic damages

Hippocampal NMDA Receptor is involved in Chronic Stress Induced Depressive-Like Behaviors via SP-NK1 Receptor Pathway

Involvement of Hippocampal NMDA Receptor and Neuropeptide Y in Depression Induced by Chronic Unpredictable Mild Stress

Involvement of Hippocampal NMDA Receptor and Nitric Oxide Synthase in Depression Induced by Chronic Unpredicted Mild Stress

The Effect of 5-HT Microinjection into Amygdaloid Nucleus on the Gastric Mobility in CUMS Treated-Rats

[Activation of Hippocampal D1 Dopamine Receptor Inhibits Glutamate-Mediated Depression Induced by Chronic Unpredictable Mild Stress in Rats].

[Hippocampus Quinolinic Acid Modulates Glutamate and NMDAR/mGluR1 in Chronic Unpredictable Mild Stress-Induced Depression].

Involvement of Hippocampal Serotonin and Neuropeptide Y in Depression Induced by Chronic Unpredicted Mild Stress

Involvenment of hippocampal glucocorticoids and BDNF in depression induced by chronic unpredictable mild stress

Glutamate Transporter 1-Mediated Antidepressant-Like Effect in a Rat Model of Chronic Unpredictable Stress

Orbitofrontal Cortex 5-HT1A Receptor Modulate Glutamate and GABA in Depression Induced by Chronic Unpredictable Mild Stress

Effect of Ginsenoside Rg1 on Behaviors and Hippocampal Amino Acids in Depressive-Like Rats

The role of astrocytes in depression, its prevention, and treatment by targeting astroglial gliotransmitter release

Depression and the Glutamate/GABA-Glutamine Cycle

RAGE Signaling pathway in hippocampus dentate gyrus involved in GLT-1 decrease induced by chronic unpredictable stress in rats